WOLVERINE ASSET MANAGEMENT LLC - PTC THERAPEUTICS INC ownership

PTC THERAPEUTICS INC's ticker is and the CUSIP is 69366JAB7. A total of 18 filers reported holding PTC THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
WOLVERINE ASSET MANAGEMENT LLC ownership history of PTC THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$19,558,000
+10.1%
19,479,000
+11.4%
0.20%
+13.3%
Q1 2022$17,762,000
-2.0%
17,479,0000.0%0.17%
+2.4%
Q4 2021$18,126,000
-0.6%
17,479,0000.0%0.17%
+7.6%
Q3 2021$18,244,000
-12.7%
17,479,000
-10.2%
0.16%
-1.3%
Q2 2021$20,896,000
-6.6%
19,454,0000.0%0.16%
-15.9%
Q1 2021$22,361,000
-10.5%
19,454,0000.0%0.19%
+3.3%
Q4 2020$24,979,000
+13.0%
19,454,0000.0%0.18%
-6.6%
Q3 2020$22,109,000
-2.2%
19,454,0000.0%0.20%
-13.7%
Q2 2020$22,604,000
+6.8%
19,454,0000.0%0.23%
-26.1%
Q1 2020$21,156,000
-10.3%
19,454,000
-4.9%
0.31%
+12.0%
Q4 2019$23,593,000
+11.0%
20,454,0000.0%0.27%
+1.9%
Q3 2019$21,253,000
-26.1%
20,454,000
-21.1%
0.27%
-28.5%
Q2 2019$28,748,000
+7.0%
25,939,0000.0%0.38%
+2.7%
Q1 2019$26,873,000
-1.7%
25,939,000
-5.5%
0.37%
+11.6%
Q4 2018$27,337,000
+81.8%
27,439,000
+111.0%
0.33%
+87.4%
Q3 2018$15,034,000
+16.4%
13,007,0000.0%0.18%
+4.8%
Q2 2018$12,915,000
+100.0%
13,007,000
+88.3%
0.17%
+98.8%
Q1 2018$6,457,000
+63.6%
6,907,000
+36.0%
0.08%
+110.0%
Q4 2017$3,946,000
+60.7%
5,079,000
+69.3%
0.04%
+48.1%
Q3 2017$2,456,0003,000,0000.03%
Other shareholders

There were no reported owners of PTC THERAPEUTICS INC in Q1 2022.

NameSharesValueWeighting ↓
View complete list of PTC THERAPEUTICS INC shareholders